相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Nikolaos G. Frangogiannis
MOLECULAR ASPECTS OF MEDICINE (2019)
Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2019)
The Drug Candidate BGP-15 Delays the Onset of Diastolic Dysfunction in the Goto-Kakizaki Rat Model of Diabetic Cardiomyopathy
Mariann Bombicz et al.
MOLECULES (2019)
Mechanisms of cardiac collagen deposition in experimental models and human disease
Randy T. Cowling et al.
TRANSLATIONAL RESEARCH (2019)
The Effects of Bradykinin B1 Receptor Antagonism on the Myocardial and Vascular Consequences of Hypertension in SHR Rats
Laszlo Deres et al.
FRONTIERS IN PHYSIOLOGY (2019)
Cardiac fibrosis - A short review of causes and therapeutic strategies
Svenja Hinderer et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
JNK and cardiometabolic dysfunction
Siobhan M. Craige et al.
BIOSCIENCE REPORTS (2019)
AMPK: a therapeutic target of heart failure-not only metabolism regulation
Xuan Li et al.
BIOSCIENCE REPORTS (2019)
Cardiac Fibroblast p38 MAPK: A Critical Regulator of Myocardial Remodeling
Neil A. Turner et al.
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2019)
Activation of mitochondrial fusion provides a new treatment for mitochondria-related diseases
Aliz Szabo et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Biomarkers for heart failure: small molecules with high clinical relevance
C. Magnussen et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Mitochondrial dysfunction in pathophysiology of heart failure
Bo Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Oxidative Stress and Cardiac Remodeling: An Updated Edge
Abeer M. Rababa'h et al.
CURRENT CARDIOLOGY REVIEWS (2018)
The RISK pathway and beyond
Xavier Rossello et al.
BASIC RESEARCH IN CARDIOLOGY (2018)
Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis
Hadi Khalil et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
BGP-15 Protects against Oxidative Stress- or Lipopolysaccharide-Induced Mitochondrial Destabilization and Reduces Mitochondrial Production of Reactive Oxygen Species
Katalin Sumegi et al.
PLOS ONE (2017)
Treatment of Hypertension: Which Goal for Which Patient?
Faical Jarraya
HYPERTENSION: FROM BASIC RESEARCH TO CLINICAL PRACTICE, VOL 2 (2017)
Impaired mitochondrial biogenesis is a common feature to myocardial hypertrophy and end-stage ischemic heart failure
Annalinda Pisano et al.
CARDIOVASCULAR PATHOLOGY (2016)
Cardiac Fibrosis The Fibroblast Awakens
Joshua G. Travers et al.
CIRCULATION RESEARCH (2016)
Regulation of cardiac hypertrophy and remodeling through the dual-specificity MAPK phosphatases (DUSPs)
Ruijie Liu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
Yow Keat Tham et al.
ARCHIVES OF TOXICOLOGY (2015)
Differential ERK1/2 Signaling and Hypertrophic Response to Endothelin-1 in Cardiomyocytes from SHR and Wistar-Kyoto Rats: A Potential Target for Combination Therapy of Hypertension
Li-an Zhu et al.
CURRENT VASCULAR PHARMACOLOGY (2015)
Mitochondrial biogenesis and dynamics in the developing and diseased heart
Gerald W. Dorn et al.
GENES & DEVELOPMENT (2015)
A quinazoline-derivative compound with PARP inhibitory effect suppresses hypertension-induced vascular alterations in spontaneously hypertensive rats
Klara Magyar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
The pathogenesis of cardiac fibrosis
Ping Kong et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice
Geeta Sapra et al.
NATURE COMMUNICATIONS (2014)
The pathophysiology of heart failure
Clinton D. Kemp et al.
CARDIOVASCULAR PATHOLOGY (2012)
Dynamics of TGF-β/Smad signaling
Zhike Zi et al.
FEBS LETTERS (2012)
BGP-15, a PARP-inhibitor, prevents imatinib-induced cardiotoxicity by activating Akt and suppressing JNK and p38 MAP kinases
Zsolt Sarszegi et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
DUSPs, to MAP kinases and beyond
Ching-Yu Huang et al.
CELL AND BIOSCIENCE (2012)
Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis
Pablo J. Fernandez-Marcos et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure
Christophe Beauloye et al.
CARDIOVASCULAR RESEARCH (2011)
AKT signalling in the failing heart
Antoine H. Chaanine et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Regulation of mitochondrial biogenesis
Francois R. Jornayvaz et al.
ESSAYS IN BIOCHEMISTRY: MITOCHONDRIAL FUNCTION (2010)
Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale
Beth A. Rose et al.
PHYSIOLOGICAL REVIEWS (2010)
BGP-15 inhibits caspase-independent programmed cell death in acetaminophen-induced liver injury
Gabor Nagy et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Rosuvastatin Attenuates Heart Failure and Cardiac Remodelling in the Ageing Spontaneously Hypertensive Rat
David Loch et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats
Eva Bartha et al.
CARDIOVASCULAR RESEARCH (2009)
PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Carles Canto et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
CREB and AP-1 activation regulates MKP-1 induction by LPS or M-CSF and their kinetics correlate with macrophage activation versus proliferation
Cristina Casals-Casas et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue
Shigeki Miyamoto et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2009)
MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets
Anthony J. Muslin
CLINICAL SCIENCE (2008)
Evaluation of blood pressure measured by tail-cuff methods (without heating) in spontaneously hypertensive rats
Yoko Kubota et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Regulation of cardiac hypertrophy by intracellular signalling pathways
Joerg Heineke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Mitochondrial ROS-induced ROS release: An update and review
Dmitry B. Zorov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2006)
Noninvasive evaluation of the time course of change in cardiac function in spontaneously hypertensive rats by echocardiography
M Kokubo et al.
HYPERTENSION RESEARCH (2005)
A model of chronic heart failure in spontaneous hypertensive rats (SHR)
G Itter et al.
LABORATORY ANIMALS (2004)
Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles
A Garnier et al.
JOURNAL OF PHYSIOLOGY-LONDON (2003)
Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system
R Halmosi et al.
MOLECULAR PHARMACOLOGY (2001)
分享论文
